Navigation Links
World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
Date:9/8/2008

BUDAPEST, Hungary and LONDON and PRINCETON, New Jersey and SAN DIEGO, California, September 8 /PRNewswire/ --

- Investment to be Used to Accelerate R&D for Continuous Process Chemistry Technologies and for Further Global Expansion

ThalesNano Inc. announced today the closing of an investment of $3.3M by a group of private and financial investors. The new private investors are Dominic Gallello, CEO of Graphisoft and Dave Tapolczay, CEO of Medical Research Council Technology and former VP of GlaxoSmithKline, the second largest pharmaceutical company worldwide. The proceeds will be used to expand R&D to further strengthen ThalesNano's leadership position in the development and implementation of continuous process technologies from research to process development and full scale production. In addition, the company will expand commercial operations and services globally with particular emphasis on the US and Asia and increase production capacity based on the high demand for its technologies and instruments.

The benefits of continuous flow technologies over conventional batch chemistry include the rapid synthesis of organic compounds, in particular under until now unrealizable hazardous reaction conditions. Further benefits include Green Chemistry by minimizing waste, energy consumption and raw material use, lab automation, and rapid scale-up from mg to kg quantities, which reduces CAPEX and OPEX while speeding time to market.

Dr. Laszlo Urge, CEO of ThalesNano said; "We are glad that our new investors clearly see the value creation of our business. We have shown significant growth over the last year in the core business. In addition, strategic partnerships were created with major pharmaceutical companies including Sanofi-Aventis SA to implement continuous process technologies on a wider scale. As a result of our intensified R&D, we expect our customers to realize additional benefits in terms of reducing development time, increasing cost efficiency and minimizing environmental impact."

Dr. Ferenc Darvas, Chairman of ThalesNano Inc. said. "Our strategy of providing a disruptive technology to the industry is working and the confidence shown by our new investors further validates this. Providing integrated continuous flow solutions from discovery to full scale production will help to solve some of the key bottlenecks in the pharmaceutical, biotechnology and chemical industries."

For more information please go to: http://www.thalesnano.com

About ThalesNano Inc.:

ThalesNano is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube(R) continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Midi(TM) are used in hundreds of laboratories in four continents and have become the new industry standard for hydrogenation. 20 out of 20 of the largest pharmaceutical companies in the world employ ThalesNano products and technologies.

Contact: Laszlo Urge, Ph.D., CEO, e-mail: ceodirect@thalesnano.com, Telephone: +36-1-880-8500


'/>"/>
SOURCE ThalesNano Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Berkeley, CA (PRWEB) , ... January 19, 2017 ... ... the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers ... Mail is a fully 21 CFR Part 11-compliant email client designed to provide ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s ... of grant applications subject to the existing policy. AMIA recommended that NIH earmark ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter ... The tremendous growth is accounted to two main factors. The first is the ... network of vendors supplying FireflySci products all around the world. , 2016 was a ...
Breaking Biology Technology:
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... --  WaferGen Bio-systems, Inc. (NASDAQ: WGBS ... that on December 13, 2016, it received a letter ... Market LLC which acknowledged that, as of December 12, ... had been at $1.00 or greater for ten consecutive ... Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
Breaking Biology News(10 mins):